GlassScriptPhysician profile
Thelma S Marin
NPI 1588621601
$1,032.03
in general payments reported to CMS, 2019-2025
21 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.87 · 2020: $131 · 2021: $152 · 2022: $79.60 · 2023: $78.57 · 2024: $251 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $221.75 | 2020-2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $90.62 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $89.03 | 2020-2024 | Airsupra, Farxiga |
| Pfizer INC. | $88.82 | 2024-2025 | |
| Abbvie INC. | $72.98 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $67.86 | 2020-2024 | Xarelto |
| Agios Pharmaceuticals, INC. | $65.45 | 2025 | Pyrukynd |
| Bayer Healthcare Pharmaceuticals INC. | $44.65 | 2023-2024 | |
| Exact Sciences Corporation | $33.86 | 2025 | The Cologuard Plus Collection Kit |
| Medtronic Minimed, INC. | $32.78 | 2019-2020 | |
| Glaxosmithkline, LLC. | $29.76 | 2022-2023 | Trelegy Ellipta |
| Biotronik Nro, INC. | $26.30 | 2024 | Prospera |
| Amgen INC. | $25.64 | 2020-2025 | Otezla, Repatha |
| Hologic Sales and Service, LLC | $21.08 | 2024 | Aptima |
| Genentech USA, INC. | $20.83 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $19.66 | 2021 | |
| Astellas Pharma US INC | $19.12 | 2023 | Veozah |
| Inspire Medical Systems, INC. | $17.83 | 2025 | Inspire |
| Seqirus USA INC | $17.72 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.02 | 2025 | Zoryve |
| Amarin Pharma, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thelma Marin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.